Short Reads

Premium

Three new hires have the discovery moxie Axiom Biotechnologies wants. Michael Kozlowski, COO, was at Bristol-Myers Squibb and Pfizer; Damien Dunnington, VP of discovery research, was at SmithKline Beecham and Aventis; and Steven Brown, director of molecular pharmacology, was with Chugai Biopharmaceuticals.

 

Hail to the chiefs:

Compugen appointed Vincent Zurawski, from UPenn’s med school, as CEO of its US subsidiary.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The US National Institutes of Health has developed guidelines to gauge whether frail chimpanzees are healthy enough to be moved to a retirement sanctuary.

Osamu Shimomura, who won the 2008 Nobel Prize in Chemistry for his work on green fluorescent protein, has died.

In PLOS this week: analytical approach for finding new genetic associations, analysis of Streptococcus pyogenes-infecting viruses, and more.

Stat News reports that the head of IBM Watson Health is leaving her post.